Abstract:BACKGROUND: Amphotericin B is firstly used to treat deeply fungous infection; however, the therapeutic effect is poor due to inability to cross the blood-brain barrier (BBB). Chitosan-poly (lactide) (chitosan-co-PLA) copolymer were synthesized by phase separation dialysis technique to overcome the shortage of amphotericin B. OBJECTIVE: To study the representation and drug-release ability of amphotericin B-loaded chitosan-co-PLA nanoparticles. DESIGN, TIME AND SETTING: A repeated measurement design was performed at the Nano-medicine and Nano-biotech Laboratory of National Center for Nanoscience and Technology from November 2008 to April 2009. MATERIALS: Chitosan with the average molecular weight of 3.4×105 and 93% deacetylation degree was produced by KaBo Biochemical Co., Shanghai. Amphotericin B was purchased from Sigma, USA. METHODS: Chitosan-polylactide copolymers were synthesized by ring-opening polymerization of DL-lactide (DLLA) and water soluble chitosan in dimethyl sulfoxide solution in the presence of triethylamine. The chitosan-polylactide copolymers, consisting of hydrophilic chitosan and hydrophobic polylactide segments, could form nanoparticles in water. Amphotericin B was incorporated into chitosan-polylactide polymeric nanoparticles by the phase separation-dialysis method. MAIN OUTCOME MEASURES: Particles size and polydispersity index were detected by laser particle size analyzer. The morphology of amphotericin B-loaded chitosan-polylactide nanoparticles was observed by environmental scanning electron microscopy. In addition, encapsulation capability, loading content and in vitro drug release of the amphotericin B nanoparticles was analyzed by UV-spectrophotometer. RESULTS: The mean diameters of chitosan-polylactide nanoparticles and amphotericin B-loaded nanoparticles were 114 nm and 153 nm (D, L-lactide/chitosan molar ratio 11:1), respectively. The nanoparticles possessed a uniform particles size distribution and spherical in shape. The entrapment efficiency and drug loading depended mainly on the copolymer composition ratio of D, L-lactide to chitosan oligomer. The encapsulation efficiency increased from (62.3±3.5)% to (90.7±2.8)%, drug loading increased from (7.8±1.2) % to (12.3±1.4) % with increasing the molar ratio of D, L-lactide to chitosan oligomer from 11 to 20. As polylactide weight ratio increased, the nanoaprticles size, encapsulation efficiency and drug-loading content increased, and the drug release rate decreased. CONCLUSION: Both ring-opening polymerization and phase separation-dialysis method are reliable and simple. The particle diameter is large, the encapsulation efficiency is great, and the in vitro drug release is sustained.

Preparation and characterization of amphotericin B-loaded silk fibroin nanoparticles-in situ hydrogel composites for topical ophthalmic application

Mucoadhesive Hybrid System of Silk Fibroin Nanoparticles and Thermosensitive In Situ Hydrogel for Amphotericin B Delivery: A Potential Option for Fungal Keratitis Treatment

Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies

Chitosan/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery

Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: In Vivo Study in a Fungal Keratitis Model.

Self-assembled sodium alginate polymannuronate nanoparticles for synergistic treatment of ophthalmic infection and inflammation: Preparation optimization and in vitro/vivo evaluation

Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis

Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.

Preparation and drug-release property of amphotericin B-loaded chitosan-polylactic acid nanoparticles

A Novel FK506 Loaded Nanomicelles Consisting of Amino-Terminated Poly(ethylene Glycol)-Block-poly(d,l)-lactic Acid and Hydroxypropyl Methylcellulose for Ocular Drug Delivery.

Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies

Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro

Silk fibroin nanoparticles for enhanced bio-macromolecule delivery to the retina

Mitigating amphotericin B cytotoxicity through gliadin-casein nanoparticles: Insights into synthesis, optimization, characterization, in vitro release and cytotoxicity evaluation

Engineered bio-adhesive polyhedral oligomeric silsesquioxane hybrid nanoformulation of amphotericin B for prolonged therapy of fungal keratitis

Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against Fusarium Solani

Preparation of Terbinafin-Encapsulated Solid Lipid Nanoparticles Containing Antifungal Carbopol® Hydrogel with Improved Efficacy: In Vitro, Ex Vivo and In Vivo Study

Preparation of the Protein/Polyphenylboronic Acid Nanospheres for Drug Loading and Unloading

Preparation and Characterization of Amorphous Amphotericin B Nanoparticles for Oral Administration Through Liquid Antisolvent Precipitation.

Novel Oleyl Amine-Modified Polymannuronic Acid Micelle Loading Tacrolimus for Therapy of Allergic Conjunctivitis.